{"version":"1.0","provider_name":"FYB Financial Yearbook","provider_url":"https:\/\/www.fyb.de\/en\/","author_name":"Tino R\u00fcb","author_url":"https:\/\/www.fyb.de\/en\/author\/onit\/","title":"Rejuvenation Biotech in Germany\/EU - FYB Financial Yearbook","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Y4YJdxw9zT\"><a href=\"https:\/\/www.fyb.de\/en\/3-fragen-an\/rejuvenation-biotech-in-germany-eu\/\">Rejuvenation Biotech in Germany\/EU<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fyb.de\/en\/3-fragen-an\/rejuvenation-biotech-in-germany-eu\/embed\/#?secret=Y4YJdxw9zT\" width=\"600\" height=\"338\" title=\"&#8220;Rejuvenation Biotech in Germany\/EU&#8221; &#8212; FYB Financial Yearbook\" data-secret=\"Y4YJdxw9zT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/08\/matthias-hornberger_450.jpg","thumbnail_width":450,"thumbnail_height":400,"description":"The topic of \"Innovative Ecosystem Biotechnology\" is one of its own in Germany. So is the extremely extensive regulatory regime. Both cultural assumptions such as the \"innovation mindset\" and historical perspectives still have a limiting effect. This shows that a considerable effort is required to keep up with the diversity of innovations internationally. VC firm KIZOO - funded by Michael Greve, former co-founder of web.de - has adopted a new focus: Accelerating Rejuvenation Biotech."}